Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 5
Submit an article Journal homepage
872
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients

Roberto FogariClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
,
Annalisa ZoppiClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
,
Amedeo MugelliniClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
,
Paola PretiClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
,
Tiziano PerroneClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
,
Pamela MaffioliClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
&
Giuseppe DerosaClinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy+390382526217; +390382526259; [email protected].
 show all
Pages 629-636 | Published online: 29 Feb 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andreas Hagendorff, Ira Kurz, Alfons Müller & Sven Klebs. (2014) Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study. Journal of Drug Assessment 3:1, pages 1-9.
Read now
Giuseppe Derosa, Arrigo F.G. Cicero, Anna Carbone, Fabrizio Querci, Elena Fogari, Angela D’Angelo & Pamela Maffioli. (2013) Olmesartan/Amlodipine Combination Versus Olmesartan or Amlodipine Monotherapies on Blood Pressure and Insulin Resistance in a Sample of Hypertensive Patients. Clinical and Experimental Hypertension 35:5, pages 301-307.
Read now

Articles from other publishers (6)

R Düsing, B Waeber, M Destro, C Santos Maia & P Brunel. (2017) Triple-combination therapy in the treatment of hypertension: a review of the evidence. Journal of Human Hypertension 31:8, pages 501-510.
Crossref
G. Kourlaba, F. Gialama, K. Tsioufis & N. Maniadakis. (2016) A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients. International Journal of Cardiology 221, pages 60-74.
Crossref
Giuseppe Derosa, Arrigo F. G. Cicero, Anna Carbone, Fabrizio Querci, Elena Fogari, Angela D’Angelo & Pamela Maffioli. (2013) RETRACTED ARTICLE: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients. Inflammation 37:1, pages 154-162.
Crossref
Pinar Kizilirmak, Yagiz Uresin & Okan Bulent Yildiz. (2012) The Efficacy and Safety of Triple vs Dual Combination of Angiotensin II Receptor Blocker and Calcium Channel Blocker and Diuretic: A Systematic Review and Meta‐Analysis. The Journal of Clinical Hypertension 15:3, pages 193-200.
Crossref
red. (2012) Sieg mit kurzem Kopf für Valsartan. CardioVasc 12:4, pages 85-85.
Crossref
Red. (2012) „Sieg mit kurzem Kopf“ für Valsartan. MMW - Fortschritte der Medizin 154:14, pages 73-73.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.